Trials / Completed
CompletedNCT06987396
Clinical Investigation to Assess the Effect of Betaglucan Administration in HPV Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Vitae Health Innovation · Industry
- Sex
- Female
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
Randomised, controlled clinical study to assess the efficacy and tolerability of an oral supplementation of 1000 mg daily of Betaglucans in the evolution of patients with Human Papilloma Virus (HPV). The improvement is measured by DNA PCR test, cytology and a specific RNA test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 1000 mg Betaglucans (daily) | Patients in the experimental group receive betaglucans supplement in capsule form, administered orally |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2025-05-15
- Completion
- 2025-05-15
- First posted
- 2025-05-23
- Last updated
- 2025-05-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06987396. Inclusion in this directory is not an endorsement.